Real Estate Healthcare Sector

Kiniksa Pharmaceuticals International

Market Cap: US$1.9b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

BGM Group

Market Cap: US$1.9b

Through its subsidiaries, operates as a pharmaceutical and chemical company in China.

Select Medical Holdings

Market Cap: US$1.9b

Through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.

Certara

Market Cap: US$1.9b

Provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally.

Enovis

Market Cap: US$1.8b

Operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally.

Alphatec Holdings

Market Cap: US$1.8b

A medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.

Tarsus Pharmaceuticals

Market Cap: US$1.8b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

Genus

Market Cap: UK£1.3b

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.

UFP Technologies

Market Cap: US$1.8b

Designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.

Supernus Pharmaceuticals

Market Cap: US$1.8b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Progyny

Market Cap: US$1.8b

A benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States.

LeMaitre Vascular

Market Cap: US$1.8b

Develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.

SS Innovations International

Market Cap: US$1.7b

Operates as a commercial-stage surgical robotics company in India and internationally.

CONMED

Market Cap: US$1.7b

A medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally.

Agios Pharmaceuticals

Market Cap: US$1.7b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

Twist Bioscience

Market Cap: US$1.7b

Manufactures and sells synthetic DNA-based products.

Recursion Pharmaceuticals

Market Cap: US$1.7b

Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.

Centessa Pharmaceuticals

Market Cap: US$1.7b

A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.

Beam Therapeutics

Market Cap: US$1.7b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

Disc Medicine

Market Cap: US$1.7b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

Bausch Health Companies

Market Cap: US$1.7b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Clover Health Investments

Market Cap: US$1.7b

Provides medicare advantage plans in the United States.

Oxford Nanopore Technologies

Market Cap: UK£1.2b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.

IDEAYA Biosciences

Market Cap: US$1.6b

A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

Endo

Market Cap: US$1.6b

A specialty pharmaceutical company, develops, manufactures, markets, and sells various pharmaceutical products in the United States and internationally.

Arcutis Biotherapeutics

Market Cap: US$1.6b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

AtriCure

Market Cap: US$1.6b

Develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.

Tivity Health

Market Cap: US$1.6b

Tivity Health, Inc. provides fitness and health products and solutions in the United States.

Summerset Group Holdings

Market Cap: NZ$2.7b

Develops, owns, and operates integrated retirement villages in New Zealand and Australia.

Biohaven

Market Cap: US$1.6b

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide.

National HealthCare

Market Cap: US$1.6b

Engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals.

Immunocore Holdings

Market Cap: US$1.6b

A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.

Schrödinger

Market Cap: US$1.6b

Develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications.

Andlauer Healthcare Group

Market Cap: CA$2.1b

A supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States.

PACS Group

Market Cap: US$1.5b

Through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States.

Ryman Healthcare

Market Cap: NZ$2.5b

Develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly people in New Zealand and Australia.